Nishimatsuya Chain Co., Ltd.
Nishimatsuya Chain Co., Ltd. (7545.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Nishimatsuya Chain Co., Ltd. (7545.T), covering cash flow, earnings, and balance sheets.
Nishimatsuya Chain Co., Ltd. (7545.T) Income Statement & Financial Overview
Review Nishimatsuya Chain Co., Ltd. 7545.T income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $43.77B | $48.69B | $43.77B | $49.75B |
Cost of Revenue | $29.16B | $31.89B | $28.94B | $31.96B |
Gross Profit | $14.62B | $16.80B | $14.83B | $17.79B |
Gross Profit Ratio | $0.33 | $0.35 | $0.34 | $0.36 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $12.98B | $13.28B | $12.76B | $12.84B |
Operating Expenses | $12.98B | $13.28B | $12.76B | $12.84B |
Total Costs & Expenses | $42.13B | $45.17B | $41.70B | $44.80B |
Interest Income | $31.00M | $0.00 | $36.00M | $36.00M |
Interest Expense | $2.00M | $0.00 | $1.00M | $0.00 |
Depreciation & Amortization | $409.00M | $339.25M | $0.00 | $339.00M |
EBITDA | $2.004B | $3.86B | $2.03B | $5.46B |
EBITDA Ratio | $0.05 | $0.08 | $0.05 | $0.11 |
Operating Income | $1.64B | $3.52B | $2.07B | $4.95B |
Operating Income Ratio | $0.04 | $0.07 | $0.05 | $0.10 |
Other Income/Expenses (Net) | $9.00M | $115.00M | -$47.00M | $165.00M |
Income Before Tax | $1.65B | $3.63B | $2.03B | $5.12B |
Income Before Tax Ratio | $0.04 | $0.07 | $0.05 | $0.10 |
Income Tax Expense | $622.00M | $1.21B | $728.00M | $1.67B |
Net Income | $1.03B | $2.42B | $1.30B | $3.45B |
Net Income Ratio | $0.02 | $0.05 | $0.03 | $0.07 |
EPS | $17.10 | $39.97 | $21.52 | $57.47 |
Diluted EPS | $17.10 | $39.97 | $21.52 | $56.99 |
Weighted Avg Shares Outstanding | $60.006M | $60.55M | $60.37M | $60.03M |
Weighted Avg Shares Outstanding (Diluted) | $60.006M | $60.55M | $60.37M | $60.54M |
The company's financials show resilient growth, with revenue advancing from $49.75B in Q1 2024 to $43.77B in Q4 2024. Gross profit remained healthy with margins at 33% in Q4 2024 compared to 36% in Q1 2024. Operating income hit $1.64B last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.004B. Net income dropped to $1.03B, while earnings per share reached $17.10. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan